Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Leishmania braziliensis-endemic area

BackgroundPentavalent antimonials (PAs) are the primary therapeutic option for American tegumentary leishmaniasis (ATL). However, the use of these drugs is complicated by adverse events (AEs), resistance and contraindications. Alternative therapies relative effectiveness is not well established.Obje...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Daniel Holanda Barroso, Renata Trindade Gonçalves, Joadyson Silva Barbosa, Jorgeth de Oliveira Carneiro da Motta, Gustavo Subtil Magalhães Freire, Ciro Martins Gomes, Raimunda Nonata Ribeiro Sampaio
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-09-01
coleção:	Frontiers in Cellular and Infection Microbiology
Assuntos:	therapy liposomal amphotericin B (LAB) N-methyl glucamine antimoniate adverse effect American cutaneous leishmaniasis (ACL) mucosal leishmaniasis
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.993338/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!